Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors

Ítems similars

• Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
  per: Tu, Yuanbiao, et al.
  Publicat: (2018)
• Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives
  per: Lu, Dong, et al.
  Publicat: (2017)
• Discovery of Triazolo-pyridazine/-pyrimidine Derivatives Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c-Met Inhibitors
  per: Zhang, Qian, et al.
  Publicat: (2020)
• Synthesis and biological evaluation of selenopyrimidine derivatives bearing thiazolyl moiety
  per: Meshari A. Alsharif
  Publicat: (2024-01-01)
• Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
  per: Muhammed Çeçen, et al.
  Publicat: (2020-11-01)